In my 30 years as breast radiologist I have always strived to be an innovator and an early adopter of the advances in breast imaging.

In the early 90’s, I integrated the clinical evaluation including the physical examination into my interpretations of mammograms of symptomatic women. In 1992 my practice was the second in California to use stereotactic needle biopsies for mammographic abnormalities.

By the next year I had introduced ultrasound as a method routinely evaluating physical and mammographic findings to diagnose cancer.  My first publication on this subject was a monograph in 1996, “Sonographic Evaluation of Benign and Malignant Lesions.”

In 1997, I realized that ultrasound was a method to find cancers not visible on the mammogram, even though screening with ultrasound had not been successful up until that time

In 1999, I built the first automated whole breast ultrasound scanner.  In the following year we found our first mammographically hidden breast cancer.

I then founded SonoCiné, Inc., which manufactures and distributes the SonoCiné 2-D automated whole breast ultrasound scanner, which is used in addition to mammography for screening dense-breasted women. I remain a Board member and Medical Director of that Company.

It has been my mission to find a way to improve on the reliability of screening mammography in women with dense breasts by using ultrasound and then to make this technology widely available.  It is also necessary to educate both physicians, who recommend breast screening to their patients, and the women who need this technology to find their breast cancers smaller and earlier.


Print Friendly